Stock Traders Purchase Large Volume of Call Options on SIGA Technologies (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) saw unusually large options trading on Wednesday. Traders acquired 1,200 call options on the stock. This represents an increase of approximately 1,438% compared to the average daily volume of 78 call options.

Hedge Funds Weigh In On SIGA Technologies

A number of large investors have recently made changes to their positions in SIGA. Wellington Management Group LLP purchased a new stake in shares of SIGA Technologies in the third quarter worth about $757,000. AltraVue Capital LLC increased its holdings in SIGA Technologies by 6.6% during the 2nd quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock worth $16,528,000 after acquiring an additional 134,450 shares during the period. Hotchkis & Wiley Capital Management LLC lifted its stake in SIGA Technologies by 152.6% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock worth $13,827,000 after purchasing an additional 1,237,620 shares in the last quarter. Harbor Capital Advisors Inc. bought a new position in SIGA Technologies in the 3rd quarter valued at $1,098,000. Finally, Foundry Partners LLC purchased a new position in shares of SIGA Technologies during the 3rd quarter valued at $2,801,000. 55.40% of the stock is owned by institutional investors.

SIGA Technologies Stock Up 1.0 %

Shares of NASDAQ:SIGA opened at $6.00 on Thursday. The firm has a market capitalization of $428.43 million, a PE ratio of 5.00 and a beta of 0.89. The company has a 50-day moving average price of $6.71 and a two-hundred day moving average price of $7.69. SIGA Technologies has a twelve month low of $4.26 and a twelve month high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.02 EPS for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. The company had revenue of $10.01 million for the quarter. Analysts anticipate that SIGA Technologies will post 1.04 earnings per share for the current fiscal year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.